A preceding study has shown that karyometry detected subvisual differences in chromatin organization status between non-recurrent and recurrent papillary urothelial neoplasm of low malignant potential (PUNLMP). The status of chromatin organization depends on epigenetic events, such as DNA methylation and histone acetylation. The aim of this study is to explore global DNA methylation and global histone acetylation in non-recurrent and recurrent PUNLMP. 5-methylcytosine (5MeC) and acetylated histone H3 lysine 9 (AcH3K9) were investigated by immunohistochemistry (IHC) in 20 PUNLMP cases (10 nonrecurrent and 10 recurrent), in 5 cases of normal urothelium (NU) and in 5 cases of muscle invasive pT2 urothelial carcinoma (UC). For global DNA methylation, the mean percentage of positive nuclei in the cells adjacent to the stroma increased from NU (79%) through non-recurrent and recurrent PUNLMP (86% and 93%, respectively) to UC (97%). The percentages of positive nuclei in the intermediate cell layers and in the superficial cells in the four groups were similar to those adjacent to the stroma. The proportion of nuclei with weak-to-moderate intensity was far greater than that of those strongly stained and increased steadily from NU to UC. For global histone acetylation, the mean percentage of positive nuclei was highest in non-recurrent PUNLMP (i.e. 90%) and lowest in recurrent PUNLMP (i.e. 81%). In NU and UC the mean percentages of positive nuclei were 84% and 86%, respectively. The percentage of positive nuclei decreased from the cell layer adjacent to the stroma to the superficial cell layer. The proportion of nuclei with weak-to-moderate intensity was slightly greater than that of those strongly stained. In comparison with global DNA methylation, the proportion of strongly stained nuclei was much higher. In conclusion, there are differences in global DNA methylation and histone acetylation patterns between non-recurrent and recurrent PUNLMP. Further studies are needed to elucidate the complex interplay between chromatin structure, its modifications and recurrence of PUNLMP.
papillary urothelial neoplasm of low malignant potential, low-grade papillary carcinoma, and highgrade papillary carcinoma (1). It replaces the 1973 WHO system which included urothelial papilloma, and papillary carcinoma of grade I, grade 2 and grade 3 (2) .
PUNLMP is a papillary urothelial lesion with an orderly arrangement of cells with minimal architectural abnormalities and minimal nuclear atypia (I). PUNLMP is a clinically important lesion because recurrence occurs in approximately 35% of patients (3) . Conventional histopathological assessment does not identify those PUNLMP cases that will recur (4) . Karyometry detects subvisual differences in chromatin organization status between non-recurrent and recurrent PUNLMP, and provides a valuable biomarker for the prediction of recurrence ofPUNLMP (5) .
The status of chromatin organization depends on epigenetic events, such as DNA methylation and histone modifications (6) (7) (8) .
Methylation of DNA, which occurs at the cytosine residues of cytosine-phospho-guanine (CpG) dinucleotides by an enzymatic reaction that produces 5-methylcytosine (5MeC), is a well characterized mechanism for epigenetic gene regulation (6, 8) . Normal and neoplastic cells may simultaneously harbor widespread (global) genomic hypomethylation, regional areas of hypermethylation, and increased DNAmethyltransferase activity (6) .
Two copies of histones H2A, H2B, H3 and H4, assembled in an octameric core with 146-147 bp of DNA tightly wrapped around it, form a nucleosome. This is the first level of chromatin organization (7) . Core histones are characterized by the presence of N-terminal tails of variable length that are reversibly modified by acetylation of lysines and methylation of lysines and argynines among others (8) (9) (10) (11) (12) (13) . In particular, acetylation of specific residues such as lysine 9 (K9) of histone 3 (H3K9) has been associated with an open chromatin configuration and a permissive transcription state (8) .
There is a correlation between the methylation state and histone modification. Genes that are methylated are usually related to deacetylated and inactive chromatin, whereas unmethylated promoters and active genes are associated with an open hyperacetylated euchromatin (6) .
A recent immunohistochemical study showed that antibodies raised against 5MeC and acetylated H3K9 (AcH3K9) successfully detected the overall epigenetic status, i.e. global DNA methylation and global histone acetylation, in pre-neoplastic and neoplastic lesions of the prostate (8) . Overall DNA methylation and global histone acetylation were investigated immunohistochemically also in oral squamous cell carcinoma and its precursors, thyroid neoplasia, lung cancer, and colon cancer (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . There are no data in the literature on the overall epigenetic status in PUNLMP.
The present study was designed to explore immunohistochemically global DNA methylation and histone acetylation in non-recurrent and recurrent PUNLMP. Similarly to the previous investigation (8) , antibodies against 5MeC and AcH3K9 were used (28) .
MATERIAL AND METHODS
For the purpose of this study twenty cases ofPUNLMP were retrieved from the five Pathology Services associated with Ancona Polytechnic University-United Hospitals. Ten were from patients who had a solitary lesion, less than I em in diameter, and were disease-free during a follow-up period of at least 8 years. This group was defined as "nonrecurrent". The other were from patients with a unifocal lesion, less than I em in diameter, who experienced one or more recurrences in the follow-up (in most of the cases the first recurrence was seen six months to one year after the removal of the primary tumor). This group was defined as "recurrent". The recurrent lesions showed a histological appearance identical to that seen in the first presentation, i.e. none of the these cases progressed to a higher grade and/or became invasive. From this group only the primary or initial tumors were included in the investigation.
The initial tumors and the recurrences were treated by trans-urethral resection of the bladder. None of the patients received adjuvant therapy, e.g. BCG or intravesical chemotherapy. As far as sex and age of the patients (mean age 61.5 years) were concerned, there were no differences when the non-recurrent and recurrent groups were compared.
The study included 5 cases of normal urothelium (NU) obtained from patients with benign prostatic hyperplasia and no history of bladder and prostate cancer, and 5 cases of bladder muscle invasive (pT2) UC without a non-invasive component. The procedure for this research project conforms to the provisions of the Declaration of Helsinki.
All the cases had been fixed in 4% butTered formaldehyde for approximately 24 hours before processing. For the purpose of this study, five-micron thick serial sections were cut from the paraffin blocks.
Immunohistochemistry
The sections were dewaxed in xylene and rehydrated through a graded series of ethanol. Antigen retrieval was done by microwave treatment for 20 min at 98°C using 0.0 I M Citric Acid butTer pH 6.0. Endogenous peroxidase activity was quenched by incubating the sections in 3% hydrogen peroxide for 10 min at room temperature. Nonspecific binding sites were blocked through pre-incubation with 5% normal goat serum in PBS for 10 min at room temperature. Reacted tissue sections were then incubated with a mouse monoclonal antibody raised against 5MeC (Aviva Systems Biology, San Diego, CA, USA, dilution I: 200) for I hour at room temperature and a rabbit polyclonal antibody raised against AcH3K9 (Cell Signalling Technology Laboratories , Danvers, MA, USA, dilution I: 100) for 18 hours at 4°C. Antigen-antibody complex was subsequently visualized using the Envision'P' Detection System kit peroxidase/DAB (DAKO, Glustrop, Denmark) and counterstained with hematoxylin. Negative controls were used for the tested antibodies; the primary antibody was replaced by either mouse or rabbit non-immune serum, as appropriate.
Evaluation ofimmunohistochemistry
For the NU and PUNLMP cases the nuclei were separately evaluated in the following three compartments: cell layer adjacent to the stroma, i.e. basal cells; superficial or luminal cell layer; and intermediate cells, i.e. those between the basal cells and superficial cells. Since a non-invasive component was not present, the nuclei were evaluated separately in the cell layer adjacent and not adjacent to the stroma . Marker staining intensity was graded as negative, weak-to-moderate and strong. No attempt was made to distinguish weak from moderate intensity. Morphologically nuclei with weak-to-moderate staining intensity displayed densely labeled spots within faintly labeled areas, whereas nuclei with strong intensity were darker and uniformly stained. At least 1,000 nuclei were evaluated in each case separately for the three compartments by a surgical pathologist, blinded to the follow-up.
Statistics
The results were presented as percentages. The mean and standard deviation (SO) for each compartment in each group were calculated. Kruskal-Wallis (KW) and Mann-Whitney (MW) tests were used as appropriate. Results were considered significant at p<0.05 . Statistics were made with SPSS software (SPSS Inc., Chicago, Illinois, USA).
RESULTS

Global DNA methylation
The nuclear immunostaining pattern of global DNA methylation in PUNLMP is shown in Fig. I . Fig. 2 shows graphically the frequency ofpositive and negative nuclei in the four diagnostic groups. The mean percentage of positive nuclei increased from NU (mean 79%, SO 6%) to non-recurrent and recurrent PUNLMP (mean 86%, SO 3% and mean 93%, SO 2%, respectively), and to UC (mean 97%, SD I%). The difference between the four groups was statistically significant (KW test; p = 0.00 I).
Cells adjacent to the stroma
Intermediate cell layers (including cell layers not adjacent to the stroma in UC)
For NU, non-recurrent and recurrent PUNLMP the mean percentages of positive nuclei were similar to those in the cells adjacent to the stroma. For UC the mean values of the nuclei adjacent and not adjacent to the stroma were similar. The difference between the four groups was statistically significant (KW test; p = 0.002). 
Superficial cells
The mean percentages of positive nuclei were similar to those in the cells adjacent to the stroma and intermediate cell layers. In NU 80% (SO 2%) of the nuclei were positive. In non-recurrent and recurrent PUNLMP the mean percentages of positive nuclei were 84% (SO 5%) and 93% (SO 3%), respectively. The difference between the three groups was statistically significant (KW test; p = 0.024).
For NU, non-recurrent and recurrent PUNLMP the difference between cells adjacent to the stroma, intermediate cells and superficial cells was not statistically significant (KW test; p = 0.955, P = 0.209 and p = 0.336, respectively). In UC the difference between the cell layer adjacent to the stroma and the intermediate cell layers was not significant (MW test; p = 0.91).
Marker staining intensity
The proportion of nuclei with weak-to-moderate intensity was far greater than that of those strongly stained and increased steadily from NU through non-recurrent and recurrent PUNLPM to lfC . The mean and SO are reported in Table I together with the results of statistical analysis.
Global histone acetylation
The nuclear immunostaining pattern of global histone acetylation in PUNLMP is shown in Fig. 3 . Fig. 4 shows graphically the frequency ofpositive and negative nuclei in the four diagnostic groups. In NU the mean percentage of positive nuclei was 84% (SO 7%). The highest mean percentage of positive nuclei was seen in non-recurrent PUNLMP (mean 90%; SO 4%), and the lowest in recurrent PUNLMP (mean 81%; SO 8%). In UC the mean percentage was slightly higher than in NU (mean 86%, SO 8%). The difference between the four groups was not statistically significant (KW test; p = 0.098).
Cells adjacent to the stroma
Intermediate cell layers (including cell layers not adjacent to the stroma in UC)
For NU, non-recurrent and recurrent PUNLMP the mean percentages of positive nuclei were intermediate between those of the cells adjacent to the stroma and those of the superficial cells (see below). The pattern in NU, non-recurrent and recurrent PUNLMP and UC was similar to that seen in the cell adjacent to the stroma. In UC the mean value ofthe nuclei not adjacent to the stroma was lower than that of the nuclei adjacent to it. The difference between the four groups was not statisticallysignificant (KW test; p = 0.115).
Superficial cells
The mean percentages of positive cells were lower than in the cells adjacent to the stroma and in the intermediate cell layers. In particular, the mean percentage of positive nuclei in NU was 65% (SO 8%). The mean percentages in non-recurrent and recurrent PUNLMP were 81% (SO 13%) and 70% (SO 5%), respectively. The difference between the three groups was not statistically significant (KW test; p = 0.181).
For NU and non-recurrent PUNLMP the differences between the values of superficial cells, intermediate cells and cells adjacent to the stroma were not statistically significant (KW test; p = 0.115 and p = 0.175, respectively). For recurrent PUNLMP, the difference between these compartments was statistically significant (KW test; p = 0.021). In UC the difference between the cell layer adjacent to the stroma and the intermediate cell layers was not significant (MW test; p = 0.85).
Marker staining intensity
The proportion of nuclei with weak-to-moderate intensity was slightly greater than that of strongly stained. The proportion of nuclei strongly stained was much higher compared with the percentage of nuclei intensely stained in global DNA methylation. The mean and SO are reported in Table II together with the results of statistical analysis.
DISCUSSION
Cancer epigenetics includes DNA methylation (29) . Compared to normal cells, DNA of cancer cells is generally hypomethylated, while promoters of certain genes are hypermethylated, in the context of CpG islands. Such promoter-specific increase in methylation leads to silencing of the affected gene that might have functioned as, for instance, a tumor suppressor. Transcriptional repression by DNA methylation is mediated by a class of methyl DNA binding proteins which, by virtue of recognizing specifically methylated DNA sequences, recruit repressive protein complexes including histone deacetylases to gene promoters (30) . The combination ofCpG island methylation, proteins that binds to them, and repressive histone modifications generates localized regions of specialized chromatin, which can inhibit transcription. Despite a growing list of genes including tumor suppressors and DNA repair genes that are aberrantly hypermethylated in different cancers, only a limited number of the identified hypermethylated genes have demonstrated any potential utility in clinical decision making.
As opposed to single-gene analysis, the integrated information on methylation patterns of multiple genes may reflect the functional status of several cellular pathways (6, 30) . Global methylation of DNA is usually quantified by chromatography (31) , whereas the methylation status of specific genes is studied by molecular hybridization or genomic sequencing (32) . These techniques require extraction of DNA and do not allow the cell integrity to be preserved. An immunohistochemical approach was developed using monoclonal antibodies that recognize the presence of a methyl group on the carbon 5 of cytosine, to investigate DNA methylation in situ, which allowed the analysis of global methylation to be performed on interphase nuclei in several cell types, on a cell by cell basis by microscopy (6) .
Our current study shows an altered global DNA methylation pattern in non-recurrent and recurrent PUNLMP. In particular, the percentage of nuclei expressing 5MeC in non-recurrent PUNLMP was greater than in NU and further increased in recurrent PUNLMP and in UC, whereas that of negative nuclei steadily decreased. The proportion of nuclei with weak-to-moderate intensity was far greater than that of those strongly stained.
Histones are subject to a variety of posttranslational modifications, including acetylation of lysines. Such modifications play fundamental roles in gene regulation and other chromatin-based processes. Histone-modifying enzymes affect histones either locally, through targeted recruitment by sequence specific transcription factors (33) , or globally throughout the genome in an untargeted manner, affecting virtually all nucleosomes (34) . Such widespread functions that occur independently of apparent sequence-specific DNA binding proteins are referred to as "global histone modifications".
Like their targeted effects, the global activity of the histone modifying enzymes can modulate gene activity (34) . Therefore, histones are modified locally and globally through multiple histonemodifying enzymes with different substrate specificities, generating hierarchical patterns of modifications from single promoters to large regions of chromosomes and even single cells.
Since histone modifications occur throughout the genome, any potential change in the activity of the histone modifying enzymes results in changes in specific histone patterns detectable at the level of individual nuclei by me. While the immunohistochemical approach provides information on global histone acetylation, it does not give information on the genomic, gene-gene differences in distribution of histone modifications. However, it reveals novel cell--eell heterogeneity in histone modification levels that would be hidden in molecular approaches such as chromatin immunoprecipitation (35) .
Our study shows an altered pattern of global histone acetylation in PUNLMP. Compared with NU and UC, the frequency of nuclei showing AcH3K9 expression increased in non-recurrent PUNLMP and then decreased in recurrent PUNLMP, while that of negative nuclei decreased in the former groups and then increased in the latter. The proportion of nuclei with weak-to-moderate intensity was slightly greater than that of those strongly stained. In comparison with global DNA methylation, the proportion of strongly stained nuclei was much higher.
Based on what has already been published (14-27, 36), we consider negative nuclei and those with weak-to-moderate intensity as unmethylated and hypomethylated, and deacetylated and hypoacetylated, respectively, whereas those strongly stained as hypermethylated and hyperacetylated. In particular, global DNA unmethylation and hypomethylation, present in the majority of nuclei across the four groups, increase in non-recurrent and recurrent PUNLMP, in comparison with NU, to become greatest in IfC, Global histone deacetylation and hypoacetylation are present in a lower proportion of nuclei compared with that of DNA unand hypomethylated nuclei, being slightly increased in PUNLMP, especially in the non-recurrent cases, in comparison with NU and UC.
Our findings on global DNA methylation and histone acetylation status are consistent with those reported in studies on prostate cancer and its precursors, oral squamous cell carcinoma and its precursors, thyroid neoplasia, lung cancer, and colon cancer (8, (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) 36) . However, in none of such investigations were the changes investigated in relation to cell compartments. Our study is the first to document that, when dealing with global DNA methylation, the proportion of positive nuclei in the cell layer adjacent to the stroma in PUNLMP is similar to that of the intermediate and superficial cell layers, whereas, when dealing with global histone acetylation, the proportion of positive nuclei decreases towards the surface of the urothelium. Such epigenetic patterns could be related to the processes of cell proliferation and differentiation.
In conclusion, the present study shows that there are differences in global DNA methylation and histone acetylation patterns between non-recurrent and recurrent PUNLMP in comparison with NU and UC. Further studies are needed to elucidate the complex interplay between chromatin structure, its modifications and recurrence of PUNLMP.
